Key statistics
On Friday, ACADIA Pharmaceuticals Inc (0A4W:LSE) closed at 16.44, 12.82% above the 52 week low of 14.57 set on Jun 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 16.44 |
Low | 16.44 |
Bid | -- |
Offer | -- |
Previous close | 16.43 |
Average volume | 550.30 |
---|---|
Shares outstanding | 165.88m |
Free float | 164.99m |
P/E (TTM) | 91.17 |
Market cap | 2.74bn USD |
EPS (TTM) | 0.1813 USD |
Data delayed at least 20 minutes, as of Sep 20 2024 17:38 BST.
More ▼
Press releases
- Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
- Ryan Reynolds Announces More to Parkinson’s® Campaign
- Acadia Pharmaceuticals to Participate in the Canaccord Genuity 44th Annual Growth Conference
- Acadia Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operating Overview
- Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2024
- Clinical Data from Open-Label Extension LILAC-1™ and LILAC-2™ Studies Evaluating Long-Term Safety and Efficacy of DAYBUE™ (trofinetide) in Patients with Rett Syndrome Published in Med
More ▼